According to a story from Newswire, the specialty pharmaceutical company Tikomed recently announced that the first patient has been dosed in an clinical trial testing the company's experimental product ILB.…
The 2018 Nobel Prize for Medicine was awarded to two researchers working on checkpoint inhibitor therapies for cancer. A source article by AFP, shared by medical express, outlines how checkpoint…
According to a story from the Evening Times, Rebecca Scott was only in her upper twenties when she was first diagnosed with ovarian cancer. It is generally uncommon for ovarian…
According to a story from abc.net.au, Cyril Wise watched in horror as his wife Kaye died of Huntington's disease in 2014. However, before his wife's death, Cyril was struck with…
According to a story from pm360online.com, the drug developer Bavarian Nordic A/S recently announced that its Phase 2 clinical trial of its experimental product BN-Brachyury has begun, with the first…
Forbes reports that Healx, a British biotech startup, is using the power of artificial intelligence to find new uses for existing drugs that treat rare diseases. "Healx combines AI technology, pharmacology…
A study, called ‘Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing’, has examined how often the results of genetic testing for cancer risk are later reclassified. To read about…
An enormous anonymous donation of more than $18 million has been given to the BC Cancer Foundation to fund cutting-edge treatments. The news was announced in an article by the…
It's shocking and quite frankly, devastating, to be diagnosed with any type of cancer at any age. It can be hard to stay positive as your life completely changes as…
According to a story from publicnow.com, the drug development company Sarepta Therapeutics recently announced that is has completed negotiations for a licensing agreement with Lysogene, a biopharmaceutical company. This agreement…
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
